Azithromycin paradox in the treatment of cystic fibrosis airway disease.

about

Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and RsmZ in Pseudomonas aeruginosa

P2860

Q28552822-5A8B41DB-39CD-44B7-AB4B-1FD9FDC78BFD Q35065762-687D73C7-3D77-4814-B557-A9705E34928D

P2860

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

Item

http://www.wikidata.org/entity/Q39835134

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

@en

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

@nl

type

Item

label

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

@en

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

@nl

prefLabel

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

@en

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

@nl

P1476

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

@en

P2093

Christopher D Sibley

http://www.w3.org/2001/XMLSchema#string

Harvey R Rabin

http://www.w3.org/2001/XMLSchema#string

Margot E Grinwis

http://www.w3.org/2001/XMLSchema#string

Michael G Surette

http://www.w3.org/2001/XMLSchema#string

P2860

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication.

Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections.

Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa.

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

Erythromycin and diffuse panbronchiolitis

The effects of macrolides on inflammatory cells.

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.

Cystic fibrosis: a polymicrobial infectious disease.

P304

1315-1319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FMB.10.99

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20860478

http://www.w3.org/2001/XMLSchema#string

P921

azithromycin

cystic fibrosis

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

about

P2860

P2860

Azithromycin paradox in the treatment of cystic fibrosis airway disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921